TOKYO -- Fujifilm Holdings, developer of anti-flu treatment Avigan, will invest about 100 billion yen ($928 million) to ramp up production of biopharmaceuticals at its plant in Denmark, the company announced Tuesday, in response to increasing demand for medicines as therapeutic agents.
